Comerica Bank
ANIK icon

Comerica Bank’s Anika Therapeutics ANIK Stock Holding History

Comerica Bank’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$673 Hold
70
– – ﹤0.01% 3615
2025
Q3 		$658 Buy
+70
New +$668 ﹤0.01% 3619
2024
Q4 		– Sell
-90
Closed -$2.22K – 3683
2024
Q3 		$2.22K Hold
90
– – ﹤0.01% 3483
2024
Q2 		$2.28K Hold
90
– – ﹤0.01% 3470
2024
Q1 		$2.29K Hold
90
– – ﹤0.01% 3508
2023
Q4 		$2.04K Buy
+90
New +$1.86K ﹤0.01% 3515
2022
Q4 		$273K Sell
8,784
-2,530
-22% -$72K ﹤0.01% 1987
2022
Q3 		$287K Sell
11,314
-1,165
-9% -$26.8K ﹤0.01% 1958
2022
Q2 		$285K Hold
12,479
– – ﹤0.01% 2015
2022
Q1 		$293K Buy
12,479
+450
+4% +$13.7K ﹤0.01% 2027
2021
Q4 		$388K Sell
12,029
-1,136
-9% -$45.5K ﹤0.01% 1943
2021
Q3 		$554K Sell
13,165
-315
-2% -$13K ﹤0.01% 1910
2021
Q2 		$558K Sell
13,480
-998
-7% -$42.5K ﹤0.01% 1984
2021
Q1 		$601K Sell
14,478
-505
-3% -$19.2K ﹤0.01% 1970
2020
Q4 		$584K Buy
14,983
+114
+0.8% +$4.33K ﹤0.01% 1953
2020
Q3 		$524K Sell
14,869
-174
-1% -$6.29K ﹤0.01% 1900
2020
Q2 		$547K Buy
15,043
+1,250
+9% +$41.2K ﹤0.01% 1823
2020
Q1 		$461K Buy
13,793
+401
+3% +$16.2K ﹤0.01% 1761
2019
Q4 		$575K Buy
13,392
+469
+4% +$27.2K ﹤0.01% 1836
2019
Q3 		$701K Sell
12,923
-245
-2% -$12.6K 0.01% 1720
2019
Q2 		$538K Sell
13,168
-911
-6% -$33.2K ﹤0.01% 1834
2019
Q1 		$447K Buy
14,079
+208
+1% +$7.12K ﹤0.01% 1930
2018
Q4 		$513K Sell
13,871
-273
-2% -$9.85K ﹤0.01% 1859
2018
Q3 		$573K Sell
14,144
-1,348
-9% -$53.3K ﹤0.01% 1834
2018
Q2 		$539K Sell
15,492
-129
-0.8% -$5.31K ﹤0.01% 1905
2018
Q1 		$711K Buy
15,621
+375
+2% +$21.2K 0.01% 1774
2017
Q4 		$937K Sell
15,246
-630
-4% -$34.9K 0.01% 1671
2017
Q3 		$859K Buy
15,876
+227
+1% +$11.9K 0.01% 1685
2017
Q2 		$741K Sell
15,649
-870
-5% -$40.1K 0.01% 1696
2017
Q1 		$756K Buy
16,519
+685
+4% +$32.7K 0.01% 1725
2016
Q4 		$792K Buy
15,834
+739
+5% +$34.2K 0.01% 1692
2016
Q3 		$723K Buy
15,095
+616
+4% +$30.4K 0.01% 1652
2016
Q2 		$696K Sell
14,479
-313
-2% -$14.7K 0.01% 1675
2016
Q1 		$716K Buy
14,792
+13
+0.1% +$527 0.01% 1627
2015
Q4 		$544K Sell
14,779
-79
-0.5% -$3.02K 0.01% 1682
2015
Q3 		$473K Sell
14,858
-14,556
-49% -$508K ﹤0.01% 1732
2015
Q2 		$972K Buy
29,414
+14,795
+101% +$528K ﹤0.01% 1780
2015
Q1 		$602K Sell
14,619
-13,477
-48% -$545K 0.01% 1689
2014
Q4 		$1.14M Buy
28,096
+13,852
+97% +$541K ﹤0.01% 1704
2014
Q3 		$522K Buy
14,244
+2,694
+23% +$116K ﹤0.01% 1754
2014
Q2 		$535K Buy
11,550
+173
+2% +$7.69K ﹤0.01% 1773
2014
Q1 		$468K Sell
11,377
-513
-4% -$19.1K ﹤0.01% 1891
2013
Q4 		$454K Buy
+11,890
New +$367K ﹤0.01% 1900

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Comerica Bank's ANIK Position: Q4 2025 in Review

Comerica Bank held its Anika Therapeutics (ANIK) position steady in Q4 2025 at 70 shares worth $673. The position accounts for ﹤0.01% of the portfolio, ranked #3615.

Comerica Bank first reported a position in ANIK in Q4 2013 and has held it in 43 quarters since. The position peaked at $1.14M in Q4 2014. 126 funds tracked by Wall St. Rank hold ANIK as of Q4 2025.

  • Comerica Bank held 70 shares of Anika Therapeutics worth $673 as of Q4 2025.
  • Comerica Bank left its Anika Therapeutics share count unchanged in Q4 2025.
  • Anika Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3615 holding.
  • Comerica Bank first reported a position in Anika Therapeutics in Q4 2013 and has held it in 43 quarters since.
  • Comerica Bank's Anika Therapeutics position peaked at $1.14M in Q4 2014.
  • 126 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.